Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1233 ARTÍCULOS , VIENDO DEL 1066 AL 1080

An overview of the possible therapeutic role of SUMOylation in the treatment of Alzheimer's disease

Marcelli S, Ficulle E, Piccolo L, Corbo M, Feligioni M.

Pharmacol Res. 2018 Apr;130:420-437. doi: 10.1016/j.phrs.2017.12.023. Epub 2017 Dec 26.

A review on the hybrids of hydroxycinnamic acid as multi-target-directed ligands against Alzheimer's disease

Zhang X, He X, Chen Q, Lu J, Rapposelli S, Pi R.

Bioorg Med Chem. 2018 Feb 1;26(3):543-550. doi: 10.1016/j.bmc.2017.12.042. Epub 2017 Dec 26.

Similar clinical improvement and maintenance after rTMS at 5 Hz using a simple vs. complex protocol in Alzheimer's disease

Alcalá-Lozano R, Morelos-Santana E, Cortés-Sotres JF, Garza-Villarreal EA, Sosa-Ortiz AL, González-Olvera JJ.

Brain Stimul. 2018 May-Jun;11(3):625-627. doi: 10.1016/j.brs.2017.12.011. Epub 2017 Dec 29.

Prion Protein as a Toxic Acceptor of Amyloid-β Oligomers

Purro SA, Nicoll AJ, Collinge J.

Biol Psychiatry. 2018 Feb 15;83(4):358-368. doi: 10.1016/j.biopsych.2017.11.020. Epub 2017 Nov 21.

Synaptotoxic Signaling by Amyloid Beta Oligomers in Alzheimer's Disease Through Prion Protein and mGluR5

Brody AH, Strittmatter SM.

Adv Pharmacol. 2018;82:293-323. doi: 10.1016/bs.apha.2017.09.007. Epub 2017 Oct 25.

New Insights Into Autophagy Dysfunction Related to Amyloid Beta Toxicity and Neuropathology in Alzheimer's Disease

Ntsapi C, Lumkwana D, Swart C, du Toit A, Loos B.

Int Rev Cell Mol Biol. 2018;336:321-361. doi: 10.1016/bs.ircmb.2017.07.002. Epub 2017 Sep 6.

Accuracy of the visual estimation method as a predictor of food intake in Alzheimer's patients provided with different types of food

Amano N, Nakamura T.

Clin Nutr ESPEN. 2018 Feb;23:122-128. doi: 10.1016/j.clnesp.2017.11.003. Epub 2017 Dec 6.

Antecedent ADHD, dementia, and metabolic dysregulation: A U.S. based cohort analysis

Fluegge K, Fluegge K.

Neurochem Int. 2018 Jan;112:255-258. doi: 10.1016/j.neuint.2017.08.005. Epub 2017 Aug 12.

Association of KIBRA polymorphism with risk of Alzheimer's disease: Evidence based on 20 case-control studies

Ling J, Huang Y, Zhang L, Wei D, Cheng W.

Neurosci Lett. 2018 Jan 1;662:77-83. doi: 10.1016/j.neulet.2017.08.057. Epub 2017 Aug 30.

Alzheimers' disease and caregiving: a meta-analytic review comparing the mental health of primary carers to controls

Ma M, Dorstyn D, Ward L, Prentice S.

Aging Ment Health. 2018 Nov;22(11):1395-1405. doi: 10.1080/13607863.2017.1370689. Epub 2017 Sep 5.

Alzheimer's disease in humans and other animals: A consequence of postreproductive life span and longevity rather than aging

Gunn-Moore D, Kaidanovich-Beilin O, Gallego Iradi MC, Gunn-Moore F, Lovestone S.

Alzheimers Dement. 2018 Feb;14(2):195-204. doi: 10.1016/j.jalz.2017.08.014. Epub 2017 Sep 30.

Adherence to Mediterranean diet and subjective cognitive function in men

Bhushan A, Fondell E, Ascherio A, Yuan C, Grodstein F, Willett W.

Eur J Epidemiol. 2018 Feb;33(2):223-234. doi: 10.1007/s10654-017-0330-3. Epub 2017 Nov 17.

Review: Impact of Helicobacter pylori on Alzheimer's disease: What do we know so far?

Doulberis M, Kotronis G, Thomann R, Polyzos SA, Boziki M, Gialamprinou D, Deretzi G, Katsinelos P, Kountouras J.

Helicobacter. 2018 Feb;23(1). doi: 10.1111/hel.12454. Epub 2017 Nov 27.

Comparative effect of statins on the risk of incident Alzheimer disease

Sinyavskaya L, Gauthier S, Renoux C, Dell'Aniello S, Suissa S, Brassard P.

Neurology. 2018 Jan 16;90(3):e179-e187. doi: 10.1212/WNL.0000000000004818. Epub 2017 Dec 15.

Circulating insulin-like growth factors and Alzheimer disease: A mendelian randomization study

Williams DM, Karlsson IK, Pedersen NL, Hägg S.

Neurology. 2018 Jan 23;90(4):e291-e297. doi: 10.1212/WNL.0000000000004854. Epub 2017 Dec 27.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias